Founded in 2002, Taibang Biologic Group (“Taibang”) is a leading Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products. The company's core business includes the development, manufacture and sale of plasma-derived products and other biopharmaceutical products.
As a leader in China's plasma-derived products industry, Taibang possesses leading international technology, one of the largest manufacturing capacities for plasma-derived products in Asia, and world-class R&D capabilities. The company's industry-leading product portfolio currently includes 10 plasma-derived products covering more than 20 specifications in three main categories: human albumin, human immunoglobulin, and human coagulation factors.
Taibang's non-plasma-derived products business segment covers a wide range of products including artificial dura, artificial spinal dura, artificial nerve conduits and anti-adhesion membranes for tendons.
In 2009, Taibang was listed on the Nasdaq Stock Exchange under the trading symbol “CBPO”. Over the course of its many years in operation, Taibang has become an industry-leading, international biopharmaceutical company. In April 2021, Taibang successfully completed its approximately $4.8 billion privatization with the support of several well-known investment funds.
With its mission to produce quality medicines that benefit humanity and its commitment to excellence and innovation, Taibang is focused on leveraging the latest R&D to manufacture top-notch products that set the standard for quality, safety and effectiveness.
Founded in 2002
产品直销至600多家医院和疾控中心
与地方政府及有影响力的民间组织合作开展多项慈善活动和公益项目，以提高社会对血友病的认识。
2016年4月，泰邦山东联合山东省扶贫办、山东省卫生计生委、山东省血液中心在山东省开展为期三年的“健康助力奔小康”健康扶贫公益活动暨“血相融、爱相拥”血友病关爱项目。通过此活动，泰邦山东依托山东卫生扶贫基金、山东省血液中心血友病诊疗中心，将在三年内向山东省贫困血友病患者陆续捐助总价值500万元的药品及救助基金，帮助贫困的血友病患者，助力于山东省偏远地区的扶贫工作。
通过奖学金计划以及对地方教育基金会的捐赠，帮助低收入患者家庭解决教育需求问题。
鼓励和组织公司各级员工及其家属通过自愿捐献血浆、参与慈善活动等方式来体现对患者的关怀。
每年4月17日世界血友病日公司都会配合血友之家捐赠人凝血因子Ⅷ，以提高社会各界对血友病的认识。泰邦集团与中国血友之家建立了长期的合作关系。
助力国家灾后紧急救援和重建工作，如为2012年云南省和2013年四川省雅安市地震灾民捐赠人血白蛋白和破伤风人免疫球蛋白等急救药品。
泰邦集团致力于为患者制造抢救生命的关键血液制品。公司回报社会、奉献爱心的善举与我们的使命息息相关，即拯救生命、提升患者生命质量。
自 2002 年成立以来，泰邦集团积极参与各种社会活动，帮助弱势群体，支持低收入患者家庭。
Taibang's Chairman and CEO Joseph Chow has over 25 years of experience in corporate finance, financial advisory and corporate management and has held senior executive and managerial positions in various well-known public and private companies.
Pang Guangli is recognized as an industry expert with over 35 years of experience in R&D, production and corporate management in China's plasma-derived products industry.
Yuan Feng has over 25 years of experience in corporate operations, finance and investment management and has held senior executive and managerial positions in various large public and private companies.
Gary Wang has over 22 years of senior management experience in finance and corporate roles in Fortune Global 500 companies and large public companies.
Sun Bing has worked for over 20 years in the medical device industry in areas including production management, marketing and corporate operations management.
Xia Nan as worked for over 27 years in human resources management and has held senior HR positions in several well-known enterprises.
Wesley Wu has over 10 years of experience in corporate strategy and investment in global healthcare industry.
